| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ivan Cordon, María Jesús Nicolás, Sandra Arrieta, Eneko Lopetegui, Jon López-Azcárate, Manuel Alegre, Julio Artieda, Miguel Valenci. Coupling in the cortico-basal ganglia circuit is aberrant in the ketamine model of schizophrenia. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 25. issue 8. 2016-05-06. PMID:25910422. |
here we stress the importance of the basal ganglia circuitry in the ketamine model of schizophrenia and leave the door open to further investigations devoted to elucidate to what extent these abnormalities also reflect the prominent neurophysiological deficits observed in schizophrenic patients. |
2016-05-06 |
2023-08-13 |
rat |
| Nese Sinmaz, Mazen Amatoury, Vera Merheb, Sudarshini Ramanathan, Russell C Dale, Fabienne Brilo. Autoantibodies in movement and psychiatric disorders: updated concepts in detection methods, pathogenicity, and CNS entry. Annals of the New York Academy of Sciences. vol 1351. 2016-01-26. PMID:26083906. |
in this review, we describe several autoimmune syndromes associated with movement and psychiatric disorders, including anti-n-methyl-d-aspartate receptor encephalitis, basal ganglia encephalitis, sydenham chorea, and autoantibody-associated psychosis and schizophrenia. |
2016-01-26 |
2023-08-13 |
Not clear |
| Mingjun Duan, Xi Chen, Hui He, Yuchao Jiang, Sisi Jiang, Qiankun Xie, Yongxiu Lai, Cheng Luo, Dezhong Ya. Altered Basal Ganglia Network Integration in Schizophrenia. Frontiers in human neuroscience. vol 9. 2015-11-03. PMID:26528167. |
altered basal ganglia network integration in schizophrenia. |
2015-11-03 |
2023-08-13 |
Not clear |
| Mingjun Duan, Xi Chen, Hui He, Yuchao Jiang, Sisi Jiang, Qiankun Xie, Yongxiu Lai, Cheng Luo, Dezhong Ya. Altered Basal Ganglia Network Integration in Schizophrenia. Frontiers in human neuroscience. vol 9. 2015-11-03. PMID:26528167. |
the basal ganglia involve in a range of functions that are disturbed in schizophrenia patients. |
2015-11-03 |
2023-08-13 |
Not clear |
| Mingjun Duan, Xi Chen, Hui He, Yuchao Jiang, Sisi Jiang, Qiankun Xie, Yongxiu Lai, Cheng Luo, Dezhong Ya. Altered Basal Ganglia Network Integration in Schizophrenia. Frontiers in human neuroscience. vol 9. 2015-11-03. PMID:26528167. |
these results identified the importance of basal ganglia in schizophrenia patients. |
2015-11-03 |
2023-08-13 |
Not clear |
| Dusan Hirjak, Robert C Wolf, Einar P Wilder-Smith, Katharina M Kubera, Philipp A Thoman. Motor abnormalities and basal ganglia in schizophrenia: evidence from structural magnetic resonance imaging. Brain topography. vol 28. issue 1. 2015-09-16. PMID:24878894. |
motor abnormalities and basal ganglia in schizophrenia: evidence from structural magnetic resonance imaging. |
2015-09-16 |
2023-08-13 |
Not clear |
| Dusan Hirjak, Robert C Wolf, Einar P Wilder-Smith, Katharina M Kubera, Philipp A Thoman. Motor abnormalities and basal ganglia in schizophrenia: evidence from structural magnetic resonance imaging. Brain topography. vol 28. issue 1. 2015-09-16. PMID:24878894. |
constituting a major relay center in the extrapyramidal motor system and being involved in the automatic execution of motor plans, an involvement of the basal ganglia with gma and schizophrenia is plausible. |
2015-09-16 |
2023-08-13 |
Not clear |
| Dusan Hirjak, Robert C Wolf, Einar P Wilder-Smith, Katharina M Kubera, Philipp A Thoman. Motor abnormalities and basal ganglia in schizophrenia: evidence from structural magnetic resonance imaging. Brain topography. vol 28. issue 1. 2015-09-16. PMID:24878894. |
the aim of this paper is to systematically review structural neuroimaging findings on gma and basal ganglia in individuals with schizophrenia. |
2015-09-16 |
2023-08-13 |
Not clear |
| Dusan Hirjak, Robert C Wolf, Einar P Wilder-Smith, Katharina M Kubera, Philipp A Thoman. Motor abnormalities and basal ganglia in schizophrenia: evidence from structural magnetic resonance imaging. Brain topography. vol 28. issue 1. 2015-09-16. PMID:24878894. |
considering the extant data, there is some evidence for volumetric and shape alterations of basal ganglia in schizophrenia being in part determined by psychopathology and gma, and not entirely explained by antipsychotic medication effects. |
2015-09-16 |
2023-08-13 |
Not clear |
| Darakhshan J Halee. 5-HT1A receptor-dependent control of nigrostriatal dopamine neurotransmission in the pharmacotherapy of Parkinson's disease and schizophrenia. Behavioural pharmacology. vol 26. issue 1-2. 2015-09-03. PMID:25503261. |
dysfunctions of the basal ganglia are associated with a number of neurological and psychiatric conditions including parkinson's disease and schizophrenia. |
2015-09-03 |
2023-08-13 |
Not clear |
| Fay Y Womer, Lei Wang, Kathryn I Alpert, Matthew J Smith, John G Csernansky, Deanna M Barch, Daniel Mama. Basal ganglia and thalamic morphology in schizophrenia and bipolar disorder. Psychiatry research. vol 223. issue 2. 2015-02-02. PMID:24957866. |
basal ganglia and thalamic morphology in schizophrenia and bipolar disorder. |
2015-02-02 |
2023-08-13 |
Not clear |
| A M García, M Redondo, A Martinez, C Gi. Phosphodiesterase 10 inhibitors: new disease modifying drugs for Parkinson's disease? Current medicinal chemistry. vol 21. issue 10. 2014-11-10. PMID:24372206. |
basal ganglia dysfunction is associated with neuropsychiatric disorders and until recently the development of pde10a inhibitors has been focused on schizophrenia. |
2014-11-10 |
2023-08-12 |
Not clear |
| Nathan L Hutcheson, David G Clark, Mark S Bolding, David M White, Adrienne C Laht. Basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication. Psychiatry research. vol 221. issue 1. 2014-11-05. PMID:24210948. |
basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication. |
2014-11-05 |
2023-08-12 |
human |
| Nathan L Hutcheson, David G Clark, Mark S Bolding, David M White, Adrienne C Laht. Basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication. Psychiatry research. vol 221. issue 1. 2014-11-05. PMID:24210948. |
we investigated the relationship between basal ganglia volume and treatment response to the atypical antipsychotic medication risperidone in unmedicated patients with schizophrenia. |
2014-11-05 |
2023-08-12 |
human |
| Jeffrey D Lenz, Mary Kay Lob. Optogenetic insights into striatal function and behavior. Behavioural brain research. vol 255. 2014-10-27. PMID:23628212. |
a vital part of the basal ganglia, the striatum is heavily implicated in both motor control and motivation-based behavior; as well as in neurological disorders and psychiatric diseases including parkinson's disease, huntington's disease, drug addiction, depression, and schizophrenia. |
2014-10-27 |
2023-08-12 |
Not clear |
| Hubert M Wichowicz, Alina Wilkowska, Zyta Banecka-Majkutewicz, Łukasz Kummer, Joanna Konarzewska, Alicja Racza. [Mineralization of the basal ganglia as the supposed cause of poor tolerance of zuclopenthixol in a patient with long-term untreated paranoid schizophrenia]. Psychiatria polska. vol 47. issue 4. 2014-09-15. PMID:24946467. |
[mineralization of the basal ganglia as the supposed cause of poor tolerance of zuclopenthixol in a patient with long-term untreated paranoid schizophrenia]. |
2014-09-15 |
2023-08-13 |
Not clear |
| K V S Hari Kumar, Pawan Dhull, Manoj Somasekharan, K Seshadr. Two interesting cases highlighting an oblivious specialty of psychoneuroendocrinology. Indian journal of medical sciences. vol 66. issue 5-6. 2014-03-26. PMID:23806989. |
our second patient was managed as schizophrenia and the evaluation revealed bilateral basal ganglia calcification and a diagnosis of fahr's disease. |
2014-03-26 |
2023-08-12 |
Not clear |
| Tobias Bracht, Susanne Schnell, Andrea Federspiel, Nadja Razavi, Helge Horn, Werner Strik, Roland Wiest, Thomas Dierks, Thomas J Müller, Sebastian Walthe. Altered cortico-basal ganglia motor pathways reflect reduced volitional motor activity in schizophrenia. Schizophrenia research. vol 143. issue 2-3. 2013-07-02. PMID:23276479. |
schizophrenia patients may use cortical pathways involving the supplementary motor area to compensate for basal ganglia dysfunction. |
2013-07-02 |
2023-08-12 |
Not clear |
| Nina Vanessa Kraguljac, Meredith Reid, David White, Rebecca Jones, Jan den Hollander, Deborah Lowman, Adrienne Carol Laht. Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis. Psychiatry research. vol 203. issue 2-3. 2013-01-28. PMID:22981426. |
decreased levels in the basal ganglia and frontal lobe were the most consistent findings in schizophrenia; decreased levels in the basal ganglia were the most consistent findings in bipolar disorder. |
2013-01-28 |
2023-08-12 |
human |
| Nina Vanessa Kraguljac, Meredith Reid, David White, Rebecca Jones, Jan den Hollander, Deborah Lowman, Adrienne Carol Laht. Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis. Psychiatry research. vol 203. issue 2-3. 2013-01-28. PMID:22981426. |
findings for cr were most consistent in the thalamus, frontal lobe and dorsolateral prefrontal cortex in schizophrenia and the basal ganglia and frontal lobe in bipolar disorder. |
2013-01-28 |
2023-08-12 |
human |